Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2000
10/19/2000WO2000061171A2 Uses of mammalian ox2 protein and related reagents
10/19/2000WO2000061069A2 Methods and compositions for use in the treatment of hyperlipidemia
10/19/2000WO2000061067A2 Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein
10/19/2000WO2000035484A3 Methods and compositions for decreasing allergic reactions to surface allergens
10/19/2000WO2000034780A3 METHODS AND COMPOSITIONS USEFUL FOR TARGETING ACTIVATED VITRONECTIN RECEPTOR αvβ¿3?
10/19/2000WO2000034485A3 Beta-1,3-galactosyltransferase homologs
10/19/2000WO2000032778A3 Methods and compositions for inhibiting neoplastic cell growth
10/19/2000WO2000032769A3 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides
10/19/2000WO2000031125A3 REGULATORY PROTEIN pKe#83 FROM HUMAN KERATINOCYTES
10/19/2000WO2000023625A3 Isolated nucleic acid molecules which encode scp proteins, and uses thereof
10/19/2000DE19915057A1 Monoklonale Antikörper gegen das humane Mcm3 Protein, Verfahren zu ihrer Herstellung und ihre Verwendung Monoclonal antibodies to human protein Mcm3, processes for their preparation and their use
10/19/2000CA2704600A1 A method for producing antibodies with increased adcc activity
10/19/2000CA2372028A1 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/19/2000CA2371929A1 Fab'-epitope complex from the hiv-1 cross-neutralizing monoclonal antibody 2f5
10/19/2000CA2371223A1 49 human secreted proteins
10/19/2000CA2371172A1 50 human secreted proteins
10/19/2000CA2370767A1 49 human secreted proteins
10/19/2000CA2370563A1 Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein
10/19/2000CA2370562A1 49 human secreted proteins
10/19/2000CA2370523A1 49 human secreted proteins
10/19/2000CA2370489A1 49 human secreted proteins
10/19/2000CA2370189A1 48 human secreted proteins
10/19/2000CA2370131A1 62 human secreted proteins
10/19/2000CA2370112A1 Uncoupling proteins
10/19/2000CA2369923A1 Detection of cancer and abnormal pregnancy using monoclonal antibodies specific for hcg isoforms
10/19/2000CA2369892A1 Method for quantifying transforming growth factor-.beta.1 and method for detecting cancer by using same
10/19/2000CA2369827A1 Separation of plasma components
10/19/2000CA2369822A1 Novel human voltage-gated potassium channel
10/19/2000CA2369578A1 Compounds and methods for therapy and diagnosis of lung cancer
10/19/2000CA2369454A1 Uses of mammalian ox2 protein and related reagents
10/19/2000CA2369413A1 Transmembrane protein expressed in prostate and other cancers
10/19/2000CA2366520A1 Anti-bacterial vaccine compositions
10/19/2000CA2365918A1 49 human secreted proteins
10/19/2000CA2365917A1 Bone morphogenic proteins
10/19/2000CA2365916A1 Novel lipoxygenase proteins and polynucleotides encoding the same
10/19/2000CA2365913A1 Tumor necrosis factor receptor homologs and nucleic acids encoding the same
10/19/2000CA2365912A1 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
10/19/2000CA2365910A1 Human proteins and polynucleotides encoding them
10/19/2000CA2365905A1 48 human secreted proteins
10/19/2000CA2365623A1 Tyrosine kinase substrate (tks) proteins
10/19/2000CA2365522A1 48 human secreted proteins
10/19/2000CA2364541A1 Genes associated with diseases of the kidney
10/19/2000CA2360318A1 A second mammalian tankyrase
10/18/2000EP1045028A1 Deoxyribonucleases
10/18/2000EP1044690A1 Applications of gamma globulin-rich plasma protein mixtures of animal origin and process for the preparation thereof
10/18/2000EP1044275A1 Mammalian matrix-type metalloprotease
10/18/2000EP1044273A2 COMPOSITIONS DERIVED FROM $i(MYCOBACTERIUM VACCAE) AND METHODS FOR THEIR USE
10/18/2000EP1044271A1 Il-1 delta dna and polypeptides
10/18/2000EP1044269A1 Human vps35/mem3-related protein
10/18/2000EP1044267A2 Novel nucleic acid and polypeptide with homology to the tnf-receptors
10/18/2000EP1044266A2 Human signal peptide-containing proteins
10/18/2000EP1044263A2 CELLS EXPRESSING ANTI-Fc RECEPTOR BINDING COMPONENTS
10/18/2000EP1044218A1 Nucleic acids encoding transferrin receptor-like proteins and products related thereto
10/18/2000EP1044217A2 Sag: sensitive to apoptosis gene
10/18/2000EP1044212A1 Human fk506 binding proteins
10/18/2000EP1044211A1 36 human secreted proteins
10/18/2000EP1044210A1 Human dendriac and brainiac-3
10/18/2000EP1044022A2 Compositions and methods for targeted delivery of factors
10/18/2000EP1044020A2 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products
10/18/2000EP1044013A2 Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancers
10/18/2000EP1043959A1 Interactive dental restorative network
10/18/2000EP0885393A4 Graphitic nanotubes in luminescence assays
10/18/2000EP0876385B1 Topiramate immunoassay, as well as analogs and antibodies
10/18/2000EP0827513A4 Methods of treatment and diagnostic visualisation, particularly in cancer
10/18/2000EP0577666B1 Polypeptides from mycobacterium paratuberculosis
10/18/2000EP0467932B1 Urokinase-type plasminogen activator receptor
10/18/2000CN1270637A Isolation of a novel senescence-factor gene, P23
10/18/2000CN1270634A Vertebrate telomerase genes and proteins and uses thereof
10/18/2000CN1270632A APPIL-a novel protein with growth effects
10/18/2000CN1270222A Human coenzyme I subunit isomer protein and its coding sequence
10/18/2000CN1270221A Human adenosine triphosphatase subunit protein and its coding sequence
10/18/2000CN1270220A Human protein related to VB12 and its coding sequence
10/18/2000CN1270061A 弯曲菌疫苗 Campylobacter vaccine
10/18/2000CN1057533C Method for producing clostridium perfringers vaccines
10/17/2000US6133427 Anti-human calcitonin monoclonal antibodies and an immunoassay utilizing said antibodies
10/17/2000US6133426 Humanized anti-IL-8 monoclonal antibodies
10/17/2000US6133423 Don-1 gene and polypeptides and uses therefor
10/17/2000US6133419 Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof
10/17/2000US6133049 Methods, agents and kits for detection of organophosphorus compounds
10/17/2000US6133017 Attenuated strain of Leishmania
10/17/2000US6133015 HHV-8+ lymphoma cell line which is HIV-, CMV-, EBV-, and which produces large amounts of uncontaminated HHV-8 virus
10/17/2000US6133007 Phosphodiesterase 8A
10/17/2000US6133006 Nucleotide sequence coding an enzmatic polypeptide associated with signal transduction; for the diagnosis and treatment of osteoporosis, inflammation, skin disorders, asthma, nervous system disorders, cancer, eating disorders and infections
10/17/2000US6133005 Enzymatic protein; for the treatment of nervous system disorders associated with thamine vitamin deficiency
10/17/2000US6132995 Detecting nucleic acid polymerase activity in sample; isolate polymerase with monoclonal antibody, remove impurties, activate nucleic acid sequence polymerization, count nucleic acid sequences associated with immobilized polymerase
10/17/2000US6132992 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
10/17/2000US6132981 Screening for human incubation with radioactivity; scanning erythrocytes for transferrin receptors, and comparing to control cell that have not been incubated with radoactivity
10/17/2000US6132980 Antibodies specific for TRP-2 a human tumor antigen recognized by cytotoxic T lymphocytes
10/17/2000US6132977 Measurement of a CNS protein in cerebrospinal or amniotic fluid
10/17/2000US6132973 Nucleotide sequence coding protein associated with gene expression; for the diagnosis, prevention, and treatment of defects associated with cell proliferation
10/17/2000US6132970 Rearranging nucleotide sequences; extending chains of nucleotide sequence with regions of both homogeneity and heterogeneity in multiple cycles, screening rearranged nucleotide sequences to detect desired properties
10/17/2000US6132960 Envelope polypeptide; for the detection of plant parasite
10/17/2000US6132732 Parvovirus capsids
10/17/2000US6132731 Murine leukemia virus vectors
10/17/2000US6132728 Hedgehog-derived polypeptides
10/17/2000US6132722 Recombinant antibody-enzyme fusion proteins
10/17/2000US6132721 Non-Toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor, and pharmaceutical compositions containing same
10/17/2000US6132719 Produced by digesting human fibrinogen with granulocyte elastase and d-domain-containing digestion products produced by digesting human stabilized fibrin with granulocyte elastase
10/17/2000US6132718 Using a vaccine comprising antibodies and anti-idiotype antibodies that mimic an epitope of antigen that is associated with a tumor or infectious agent.
10/17/2000US6132717 Administering to said mammals an endoproteolytically active amount of furin produced by a eukaryotic host cell.